Forest Investigative Site 1218 — Carnegie, Pennsylvania

Forest Investigative Site 1218 is a clinical research site located in Carnegie, Pennsylvania, United States 15106.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 1218 has participated in 1 clinical trials.

Therapeutic areas: Stage 1 Hypertension, Stage 2 Hypertension.

Sponsors: Forest Laboratories.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Carnegie

Browse all research sites in Pennsylvania · View every site in Carnegie

• GSK Investigational Site
• Pfizer Investigational Site
• Preferred Primary Care Physicians
• Investigational Site Number 840016
• Preferred Primary Care Phys
• Teva Investigational Site
• 205.452.01143 Boehringer Ingelheim Investigational Site
• Furiex Research Site
• AAC Institute Clinic (ICAN Talk Clinic)
• Carnegie Pediatrics
• Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 1218?

Forest Investigative Site 1218 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 1218 conducted?

Forest Investigative Site 1218 has 1 clinical trials on record. Their work covers Stage 1 Hypertension, Stage 2 Hypertension.

Is Forest Investigative Site 1218 accredited by Crixeo Clinical Trials?

Forest Investigative Site 1218 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 1218?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.